Phase II Study [resa]    
Systemic Chemotherapy [topp]    
Advanced [qlco]    
Unresectable [clna]    
hepatobiliary [bdsy]    
Carcinomas [neop]    
Aims [idcn]    
Patients [podg]    
Advanced [qlco]    
Unresectable [clna]    
hepatobiliary [bdsy]    
Carcinomas [neop]    
Efficacy [qlco]    
Systemic Chemotherapy [topp]    
Patients [podg]    
Negligible [qlco]    
Often [tmco]    
Patients [podg]    
Hepatocellular Carcinomas [neop]    
toxicity [qlco]    
Chemotherapy [topp]    
Palliative [hcro]    
NEW [qlco]    
Agent [chvf]    
MILD [qlco]    
toxicity [qlco]    
Profile [lbpr]    
Activity [ftcn]    
solid tumors [neop]    
investigated [ftcn]    
Patients [podg]    
Advanced [qlco]    
Hepatocellular [qlco]    
Cholangiocellular Carcinomas [neop]    
Phase II Study [resa]    
twenty [aggp]    
Patients [podg]    
Cholangiocellular Carcinoma [neop]    
Patients [podg]    
HEPATOCELLULAR CARCINOMA [neop]    
Study [mnob]    
Eighteen [qnco]    
Patients [podg]    
Hepatocellular Carcinomas [neop]    
LIVER CIRRHOSIS [dsyn]    
Administered [ftcn]    
Once Weekly [tmco]    
3 Weeks [tmco]    
Consecutive [qlco]    
4 Weeks [tmco]    
Patients [podg]    
Cholangiocellular Carcinomas [neop]    
RECEIVED [qlco]    
Cycle [tmco]    
Rest [dora]    
Following [tmco]    
Cycle [tmco]    
Disease status [clna]    
Assessed [acty]    
4 Weeks [tmco]    
Regimen [topp]    
Well [qlco]    
Median [spco]    
Administration [ocac]    
Range [qnco]    
Group [idcn]    
Patients [podg]    
Cholangiocellular Carcinomas [neop]    
Range [qnco]    
Group [idcn]    
Patients [podg]    
Hepatocellular Carcinomas [neop]    
Group [idcn]    
Patients [podg]    
Hepatocellular Carcinomas [neop]    
thrombocytopaenia [fndg]    
Side Effect [patf]    
Grade 4 [qlco]    
Patients [podg]    
Cholangiocellular Carcinomas [neop]    
NAUSEA [sosy]    
NEUTROPENIA [dsyn]    
Observed [ftcn]    
side effects [ftcn]    
Overall Response [fndg]    
Hepatocellular Carcinomas [neop]    
Chemotherapy [topp]    
Tumour NOS [neop]    
symptoms [ftcn]    
Patients [podg]    
Group [idcn]    
Contrast [irda]    
Group [idcn]    
Cholangiocellular Carcinomas [neop]    
Seven [qnco]    
Patients [podg]    
Partial Response [fndg]    
Overall Response [fndg]    
Eleven [qnco]    
Patients [podg]    
Cholangiocellular Carcinomas [neop]    
Revealed [qlco]    
Tumour NOS [neop]    
symptoms [ftcn]    
Onset [qnco]    
treatment [ftcn]    
Seven [qnco]    
Patients [podg]    
treatment [ftcn]    
Related [qlco]    
Benefit [qnco]    
Defined [inpr]    
Relief [fndg]    
Tumour NOS [neop]    
symptoms [ftcn]    
Gain [qnco]    
Weight [orga]    
Conclusions [idcn]    
treatment [ftcn]    
Cholangiocarcinomas [neop]    
effective [qlco]    
Evaluated [hlca]    
Phase III Study [resa]    
Contrast [irda]    
Palliative [hcro]    
Chemotherapy [topp]    
Recommended [idcn]    
Patients [podg]    
HEPATOCELLULAR CARCINOMA [neop]    
LIVER CIRRHOSIS [dsyn]    
